+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

C

Actively Recruiting

Atrial fibrillation is the most common heart rhythm disorder, increasing the risk of blood clots forming in the heart, especially in the left atrium. These clots can cause strokes if they travel to the brain. Patients with atrial fibrillation who have had an intracranial bleed bleeding in the brain are often treated with blood thinners to prevent stroke, but these medications can increase bleeding risk. This study compares two treatment methods to prevent strokes in such patients blood thinners and a device that closes off the left atrial appendage of the heart. The study randomly assigns participants to one of two groups. One group receives a device called Watchman or Watchman FLX to close the left atrial appendage through a minimally invasive procedure, followed by short-term blood thinning medication. The other group receives standard oral blood thinners as per current guidelines. Only approved drugs and devices are used. The trial aims to provide data to help doctors manage patients with atrial fibrillation who have experienced brain bleeds. Participants are followed for up to three years after randomization. Researchers monitor for events such as death from cardiovascular causes, stroke, systemic embolism, and bleeding episodes. Assessments include imaging during the procedure and regular follow-up visits to track health outcomes. The main measure is event-free survival without these complications. This long-term follow-up helps evaluate the safety and effectiveness of each treatment approach in preventing strokes and bleeding.

Age: 18Years +All GendersPhase Not Applicable
39 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are exploring the use of spontaneous eye blinking characteristics to help diagnose and predict recovery in patients with Disorders of Consciousness DoC after severe acquired brain injury sABI. This multi-center, prospective observational study involves adults with DoC, including Unresponsive Wakefulness Syndrome UWS and Minimally Conscious State MCS, admitted to several European neurorehabilitation centers. The study focuses on improving diagnostic and prognostic tools by examining eye blink parameters such as rate, amplitude, duration, and variability. Participants include 70 patients with DoC and a reference group of 23 healthy volunteers balanced by age and sex. Each patient undergoes two 20-minute EEG-EOG resting examinations within two weeks of study entry, spaced 24 hours apart, with recordings made while awake and in a quiet environment. Eye blinking is monitored at the bedside or in a wheelchair, with arousal facilitation protocols used if needed. A six-month follow-up assessment is also planned to evaluate outcomes. During the study, patients are assessed using the Coma Recovery Scale-Revised CRS-R before and after EEG-EOG recordings. Data collection follows routine clinical practice without deviations. Researchers will analyze blink features and clinical scores to evaluate diagnostic and prognostic value. The study spans approximately 24 months with enrollment over 12 months, and safety monitoring includes repeated EEG sessions if artifacts occur. Healthy volunteers also undergo two EEG-EOG sessions to provide comparison data.

Age: 18Years +All Genders
8 locations